Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

This study has been terminated.
(Total number of pts expected to be enrolled would not be met.)
Information provided by (Responsible Party):
Recepta Biopharma Identifier:
First received: May 31, 2010
Last updated: January 5, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2015
  Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)